5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.24▼ | 2.24▼ | 2.23▼ | 2.30▼ | 2.12▲ |
MA10 | 2.29▼ | 2.29▼ | 2.29▼ | 2.27▼ | 1.97▲ |
MA20 | 2.32▼ | 2.33▼ | 2.33▼ | 2.14▲ | 1.57▲ |
MA50 | 2.35▼ | 2.30▼ | 2.26▼ | 1.88▲ | 1.80▲ |
MA100 | 2.27▼ | 2.16▲ | 2.14▲ | 1.53▲ | 2.26▼ |
MA200 | 2.15▲ | 2.03▲ | 1.97▲ | 1.67▲ | 1.84▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.018▼ | -0.024▼ | -0.028▼ | -0.007▼ | 0.119▲ |
RSI | 28.989▼ | 33.620▼ | 36.623▼ | 55.002▲ | 60.450▲ |
STOCH | 27.546 | 17.130▼ | 16.412▼ | 67.835 | 63.830 |
WILL %R | -97.222▼ | -97.619▼ | -97.619▼ | -55.102 | -29.714 |
CCI | -155.606▼ | -151.941▼ | -147.810▼ | 10.992 | 82.936 |
Wednesday, July 02, 2025 07:05 PM
Aytu BioPharma, Inc. (NASDAQ:AYTU) is among the best growth stocks to invest in for the next 5 years. On Monday, Aytu BioPharma, Inc. (NASDAQ:AYTU) disclosed that it has successfully extended its ...
|
Monday, June 09, 2025 11:58 AM
Aytu BioPharma has signed an exclusive agreement with Fabre-Kramer Pharmaceuticals to commercialise Exxua (gepirone) extended-release tablets, a new antidepressant, to the US market for major ...
|
Friday, June 06, 2025 05:00 AM
Aytu enters the over $22 billion United States prescription major depressive disorder market with the first-in-class oral selective serotonin 5 HT1a receptor agonist for adults with MDD.. EXXUA ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 2.27 | 2.3607 | 2.17 | 2.18 | 96,997 |
10/07/25 | 2.40 | 2.40 | 2.26 | 2.29 | 133,256 |
09/07/25 | 2.38 | 2.3995 | 2.26 | 2.36 | 139,926 |
08/07/25 | 2.36 | 2.40 | 2.32 | 2.34 | 229,763 |
07/07/25 | 2.41 | 2.4104 | 2.3331 | 2.35 | 141,655 |
03/07/25 | 2.31 | 2.45 | 2.27 | 2.385 | 172,522 |
02/07/25 | 2.26 | 2.35 | 2.2485 | 2.29 | 156,883 |
01/07/25 | 2.24 | 2.2981 | 2.12 | 2.26 | 190,112 |
30/06/25 | 2.17 | 2.40 | 2.09 | 2.18 | 945,297 |
27/06/25 | 2.12 | 2.16 | 2.04 | 2.10 | 58,002 |
|
|
||||
|
|
||||
|
|